P.A.L.M. Microlaser Technologies GmbH Company Profile

20:20 EDT 23rd March 2018 | BioPortfolio

P.A.L.M. Microlaser Technologies GmbH is the world leader in non-contact microdissection and micromanipulation systems using the patented LMPC-technology (Laser Microdissection and Pressure Catapulting).P.A.L.M. has been able to create a platform for a key technology serving medical, biological and pharmaceutical research. This was only possible with the modular concept of the PALM MicroLaser Systems, tailor-made accessories and consumables and high quality scientific support by our Application Laboratory.
The company was founded in 1993 by Dr. Karin Schütze and her husband Raimund Schütze. From its location near Munich/ Germany the PALM MicroLaser Systems have been spread around the world and have gained a well-known reputation.
In 2001 Karin and Raimund Schütze were honored with the Philip Morris research award for the development of marketable micromanipulation systems.
Creative innovations combined with the potential of an international established organization resulted in the integration of P.A.L.M. into Carl Zeiss in December 2004. Since March 1st, 2006 P.A.L.M. is a 100% subsidiary of the Carl Zeiss MicroImaging GmbH.
Also in the future P.A.L.M. Microlaser Technologies will stand for highest competence in Technology and Service in all fields of microdissection and micromanipulation


Am Neuland 9 + 12


Phone: 49 (0) 8158 9971 0
Fax: 49 (0) 8158 9971 249

News Articles [435 Associated News Articles listed on BioPortfolio]

Researchers create microlaser that flies along hollow optical fiber

(The Optical Society) For the first time, researchers have optically trapped and propelled a particle-based laser for centimeters inside an optical fiber.

Original-Research: Medigene AG (von EQUITS GmbH): Kaufen

Original-Research: Medigene AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Medigene AG Unternehmen: Medigene AG ISIN: DE000A1X3W00 Anlass der Studie: Übernahme-Angebot Empfehlung: Kaufen Kursz...

NexWafe GmbH schließt Finanzierung in Höhe von 8 Millionen Euro ab

NexWafe GmbH, ein Spin-off des Fraunhofer ISE, das eine bahnbrechende Technologie zur epitaktischen Herstellung von Siliziumwafern für Photovoltaik kommerzialisiert, gab heute den Abschluss einer F...

20152023 World Foamed Packaging Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 16022018] Prices from USD $2800

SummaryxxxThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and...

Global and China Nano Copper Oxide Market Research by Company, Type Application 20132025 [Report Updated: 09032018] Prices from USD $2000

SummaryMarket Segment as follows:By Type Purity: 99% Purity: 90% OthersBy Application Electricals Electronics Paints Coatings Catalysts Energy Storage OthersBy Company Inf...

Gerresheimer-Aktie: Dividendenerhöhung auch für 2018? Kaufempfehlung

Frankfurt am Main - Gerresheimer-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, nehmen in einer aktuellen Aktienanalyse die Coverage....

Park Place Technologies Acquires Axentel Technologies

The Axentel Technologies acquisition allows Park Place Technologies to significantly enhance its ability to service customers in Singapore, Malaysia, Hong Kong, Thailand Read more...

Park Place Technologies adquiere Axentel Technologies

La adquisición de Axentel Technologies permite a Park Place Technologies mejorar considerablemente su capacidad de prestar servicios a clientes en Singapur, Malasia, Hong Kong, Read more...

PubMed Articles [349 Associated PubMed Articles listed on BioPortfolio]

Health technology assessments conducted in health care facilities: A strategic practice? Findings from a content analysis of HTA reports.

In this paper, we test the hypothesis that health technology assessment units located in hospitals tend to be more optimistic toward technologies that are currently in use in their organization than t...

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Three-dimensional Technologies in Orthopedics.

New 3-dimensional digital technologies are revolutionizing orthopedic clinical practice, allowing structures of any complexity to be manufactured in just hours. Such technologies can make surgery for ...

A brief review of single-cell transcriptomic technologies.

In recent years, there has been an effort to develop new technologies for measuring gene expression and sequence information from thousands of individual cells. Large data sets that were obtained usin...

On the Cusp of a Healthcare Revolution: BME Technologies Have the Potential to ?Transform Our World?

Of the key technologies listed as "ready to propel industries and transform our world" in the 2017 report Top 50 Emerging Technologies: Growth Opportunities of Strategic Imperative, most fall under th...

Clinical Trials [402 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Companies [1770 Associated Companies listed on BioPortfolio]

P.A.L.M. Microlaser Technologies GmbH

P.A.L.M. Microlaser Technologies GmbH is the world leader in non-contact microdissection and micromanipulation systems using the patented LMPC-technology (Laser Microdissection and Pressure Catapultin...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...


GYMWATCH GmbH develops advanced fitness technologies and devices. Based in Darmstadt, Germany, near Frankfurt, the company’s first product is the patented GYMWATCH Sensor, wh...

More Information about "P.A.L.M. Microlaser Technologies GmbH" on BioPortfolio

We have published hundreds of P.A.L.M. Microlaser Technologies GmbH news stories on BioPortfolio along with dozens of P.A.L.M. Microlaser Technologies GmbH Clinical Trials and PubMed Articles about P.A.L.M. Microlaser Technologies GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of P.A.L.M. Microlaser Technologies GmbH Companies in our database. You can also find out about relevant P.A.L.M. Microlaser Technologies GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record